Home News & Events Social media Social media Page tools Share Share Share on FacebookShare on XShare on LinkedinShare on Bluesky Print Search Email Accessibility What’s happening in ICON ICON Plc With trial complexity and costs rising, sponsors are shifting from WHETHER to use DHTs to HOW to integrate them responsibly and at scale. With regulators like the FDA and EMA actively encouraging patient-centric and real... 21h View post View webpage ICON Plc In this article, our data standards experts Kent Letourneau and Sandra Minjoe explain how sponsors can efficiently prepare clinical data submissions that meet both FDA and PMDA requirements, by leveraging the substantial... 23h View post View webpage ICON Plc PLATO 11 is a new, validated, freely accessible PRO instrument developed by ICON’s Patient Centred Outcomes and the American Academy of Sleep Medicine to fill a critical gap in patient centred assessment for obstructive ... 9 Feb View post View webpage ICON Plc Latest issue out now. Keep up to date on the most recent regulatory changes in the world of pharma, biotech and medical device clinical trials with ICON’s Regulatory Intelligence Newsletter. Join thousands of subscribe... 9 Feb View post View webpage ICON Plc 1 in 5 people will develop heart failure in their lifetime. ICON recognises the importance to raise global awareness of heart failure risk factors such as hypertension, obesity, diabetes and coronary heart disease. Dis... 9 Feb View post View webpage ICON Plc Next week ICON Biotech sponsors #OCTWestCoast! Drop by booth \#79 to speak with our experts, including Travis Caudill VP who will be giving a special featured presentation and appearing on a panel to discuss the latest A... 6 Feb View post View webpage ICON Plc ICON is proud to support Heart Failure Awareness Week. As a global leader in cardiovascular trials, we remain committed to raising awareness and advancing better, safer and more cost‑effective therapies for people living... 6 Feb View post View webpage ICON Plc ICON is a proud sponsor of this year’s #ISCR Annual Conference, taking place in New Dehli from 13 – 14 February. Visit the ICON team at booth #G-11 to learn about our high-quality, global services and solutions to suppor... 5 Feb View post View webpage ICON Plc There is great excitement following the announcements by the FDA and EMA around streamlining the biosimilar trial process. They promise to reduce the burden on developers and therefore increase the number of more afford... 5 Feb View post View webpage ICON Plc In oncology, a single biomarker usually is not enough to provide useful information about a patient’s cancer or response to treatment, and the relationships between individual biomarkers can be difficult to establish or ... 4 Feb View post View webpage ICON Plc This World Cancer Day, we honour everyone affected by cancer — patients, families, clinicians, researchers, and the teams working tirelessly to advance care. Recent work done by Symphony Health, an ICON plc company, ana... 4 Feb View post View webpage ICON Plc In 2025 ICON’s Creative and Digital Services and Global Medical Communications teams were recognised for delivering impactful medical communications for clients. https://ow.ly/ncCE50XSQ0P 30 Jan View post View webpage
